glp-1 and uti receptor agonists next-generation metabolic hormone therapies in chronic kidney disease Evolution of incretin therapeutics. (A)

A number of plaintiffs sued the FDA in 2024, seeking a preliminary injunction to permit ongoing compounding

Results from orchestra, a phase II proof-of-concept study assessing the efficacy and safety of minzasolmin in people with early-stage PD [abstract]

Frozen Detox is a dietary supplement for body detoxification

doi: 10.1073/pnas.0603290103

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals genetic predispositions in key peptide and cardiovascular pathwaysincluding variants in the GLP1R and GIPR genesthat may help provide context for how your body responds to GLP-1 therapy